| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Accelerating clinical development timelines
|
Pretorius, Sy
|
|
2018
|
23 |
7 |
p. 1319-1320
|
artikel
|
| 2 |
A tumor multicomponent targeting chemoimmune drug delivery system for reprograming the tumor microenvironment and personalized cancer therapy
|
Sau, Samaresh
|
|
2018
|
23 |
7 |
p. 1344-1356
|
artikel
|
| 3 |
‘Bioexit’: navigating the policy and regulatory pathways for the biotechnology industry in a post-Brexit landscape
|
Mackey, Tim K.
|
|
2018
|
23 |
7 |
p. 1324-1327
|
artikel
|
| 4 |
Can we accelerate medicinal chemistry by augmenting the chemist with Big Data and artificial intelligence?
|
Griffen, Edward J.
|
|
2018
|
23 |
7 |
p. 1373-1384
|
artikel
|
| 5 |
Computational modeling approaches to quantitative structure–binding kinetics relationships in drug discovery
|
De Benedetti, Pier G.
|
|
2018
|
23 |
7 |
p. 1396-1406
|
artikel
|
| 6 |
Contents page 2
|
|
|
2018
|
23 |
7 |
p. ii
|
artikel
|
| 7 |
Contents page 1
|
|
|
2018
|
23 |
7 |
p. i
|
artikel
|
| 8 |
EU decision-making for marketing authorization of advanced therapy medicinal products: a case study
|
de Wilde, Sofieke
|
|
2018
|
23 |
7 |
p. 1328-1333
|
artikel
|
| 9 |
Extension of quality-by-design concept to the early development phase of pharmaceutical R&D processes
|
Csóka, Ildikó
|
|
2018
|
23 |
7 |
p. 1340-1343
|
artikel
|
| 10 |
Mesenteric ischemia-reperfusion: an overview of preclinical drug strategies
|
Bertoni, Simona
|
|
2018
|
23 |
7 |
p. 1416-1425
|
artikel
|
| 11 |
Nanogels as potential drug nanocarriers for CNS drug delivery
|
Vashist, Arti
|
|
2018
|
23 |
7 |
p. 1436-1443
|
artikel
|
| 12 |
Prediction of brain:blood unbound concentration ratios in CNS drug discovery employing in silico and in vitro model systems
|
Liu, Houfu
|
|
2018
|
23 |
7 |
p. 1357-1372
|
artikel
|
| 13 |
Real-world evidence approach to traditional herbal medicinal products
|
Weng, Xinyu
|
|
2018
|
23 |
7 |
p. 1321-1323
|
artikel
|
| 14 |
Strategic R&D transactions in personalized drug development
|
Makino, Tomohiro
|
|
2018
|
23 |
7 |
p. 1334-1339
|
artikel
|
| 15 |
Structural basis for selective inhibition of antibacterial target MraY, a membrane-bound enzyme involved in peptidoglycan synthesis
|
Hering, Jenny
|
|
2018
|
23 |
7 |
p. 1426-1435
|
artikel
|
| 16 |
Targeting cancer metabolism to develop human lactate dehydrogenase (hLDH)5 inhibitors
|
Zhang, Shao-Lin
|
|
2018
|
23 |
7 |
p. 1407-1415
|
artikel
|
| 17 |
Targeting HIF-2α as therapy for advanced cancers
|
Murugesan, Thanabal
|
|
2018
|
23 |
7 |
p. 1444-1451
|
artikel
|
| 18 |
The neuroprotective role of the brain opioid system in stroke injury
|
Vaidya, Bhuvaneshwar
|
|
2018
|
23 |
7 |
p. 1385-1395
|
artikel
|
Tijdschrift beschrijving